Atin Tomar – Yapan Bio
View Detailed Executive Profile →Professional Overview
- Atin Tomar founded Yapan Bio in January 2019, taking on the role of Founder & CEO, with a vision to innovate in the biotechnology sector.
- Prior to establishing Yapan Bio, Atin served as President & CEO at CPL Biologicals Pvt. Ltd. from 2016 until early 2019, demonstrating leadership in the biopharmaceutical industry.
- Atin held the position of Director of Business Development, Alliance & Program Management at the International Vaccine Institute from 2015, contributing to global health initiatives through partnership management.
- As Vice President of Business Development, Program and Alliance Management at MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. from 2012 to 2015, Atin played a significant role in advancing vaccine research and development.
- In the capacity of Associate Director of Business Development - Biologics at Dr. Reddy's Laboratories from 2010 to 2012, Atin specialized in strategic collaborations and product development in biologics.
- Atin's early career included a role as Scientific Manager, Head - Biologics at Syngene International Limited from 2006 to 2009, overseeing scientific projects in biologics.
- Atin worked as Engineer II at Amgen from 2003 to 2006, focusing on engineering processes within a global biotech leader.
- Atin began a career in biotechnology as a Bioprocess Engineer I at Human Genome Sciences from 2002 to 2003, contributing to the pioneering work in human genetics.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| CPL Biologicals Pvt. Ltd. | President & CEO | Jan 2016 – Jan 2019 |
| International Vaccine Institute | Director of Business Development, Alliance & Program Management | Jan 2015 – Jan 2015 |
| MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Vice President - Business Development, Program and Alliance Management | Jan 2012 – Jan 2015 |
| Dr. Reddy's Laboratories | Associate Director, Business Development - Biologics | Jan 2010 – Jan 2012 |
| Syngene International Limited | Scientific Manager, Head - Biologics | Jan 2006 – Jan 2009 |
| Amgen | Engineer II | Jan 2003 – Jan 2006 |
| Human Genome Sciences | Bioprocess Engineer I | Jan 2002 – Jan 2003 |
| Yapan Bio | Founder & CEO | Jan 2019 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Yapan Bio corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Atin Tomar's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Yapan Bio's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)